IL41902A - Immunogenic substance,its production,vaccine preparations containing it and their preparation - Google Patents
Immunogenic substance,its production,vaccine preparations containing it and their preparationInfo
- Publication number
- IL41902A IL41902A IL41902A IL4190273A IL41902A IL 41902 A IL41902 A IL 41902A IL 41902 A IL41902 A IL 41902A IL 4190273 A IL4190273 A IL 4190273A IL 41902 A IL41902 A IL 41902A
- Authority
- IL
- Israel
- Prior art keywords
- vaccine
- substance
- immunogenic substance
- multocida
- immunogenic
- Prior art date
Links
- 239000000126 substance Substances 0.000 title claims 30
- 229960005486 vaccine Drugs 0.000 title claims 30
- 230000002163 immunogen Effects 0.000 title claims 22
- 238000002360 preparation method Methods 0.000 title 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 claims 13
- 241000606856 Pasteurella multocida Species 0.000 claims 9
- 241000124008 Mammalia Species 0.000 claims 6
- 241001293418 Mannheimia haemolytica Species 0.000 claims 5
- 238000002649 immunization Methods 0.000 claims 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 5
- 231100000419 toxicity Toxicity 0.000 claims 4
- 230000001988 toxicity Effects 0.000 claims 4
- 206010034107 Pasteurella infections Diseases 0.000 claims 3
- 244000309725 Pasteurella multocida type A Species 0.000 claims 3
- 239000004480 active ingredient Substances 0.000 claims 3
- 201000005115 pasteurellosis Diseases 0.000 claims 3
- 241000283973 Oryctolagus cuniculus Species 0.000 claims 2
- 208000008939 Pneumonic Pasteurellosis Diseases 0.000 claims 2
- 239000002671 adjuvant Substances 0.000 claims 2
- 239000008280 blood Substances 0.000 claims 2
- 210000004369 blood Anatomy 0.000 claims 2
- 239000002158 endotoxin Substances 0.000 claims 2
- 230000036039 immunity Effects 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 241000193738 Bacillus anthracis Species 0.000 claims 1
- 241000206044 Clostridium chauvoei Species 0.000 claims 1
- 241000193466 Clostridium septicum Species 0.000 claims 1
- 208000032969 Hemorrhagic Septicemia Diseases 0.000 claims 1
- 241000282412 Homo Species 0.000 claims 1
- 208000006666 Shwartzman Phenomenon Diseases 0.000 claims 1
- 231100000702 Shwartzman phenomenon Toxicity 0.000 claims 1
- 159000000013 aluminium salts Chemical group 0.000 claims 1
- 229910000329 aluminium sulfate Inorganic materials 0.000 claims 1
- 239000008346 aqueous phase Substances 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 210000003837 chick embryo Anatomy 0.000 claims 1
- 239000012153 distilled water Substances 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 239000003995 emulsifying agent Substances 0.000 claims 1
- 231100000636 lethal dose Toxicity 0.000 claims 1
- 231100000252 nontoxic Toxicity 0.000 claims 1
- 230000003000 nontoxic effect Effects 0.000 claims 1
- 229940051027 pasteurella multocida Drugs 0.000 claims 1
- 230000001698 pyrogenic effect Effects 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
- 239000007762 w/o emulsion Substances 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1491072 | 1972-03-29 | ||
| GB593573*[A GB1441098A (en) | 1972-03-29 | 1973-02-07 | Biological preparations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL41902A0 IL41902A0 (en) | 1973-05-31 |
| IL41902A true IL41902A (en) | 1976-03-31 |
Family
ID=26240265
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL41902A IL41902A (en) | 1972-03-29 | 1973-03-28 | Immunogenic substance,its production,vaccine preparations containing it and their preparation |
Country Status (9)
| Country | Link |
|---|---|
| JP (1) | JPS496118A (Direct) |
| DE (1) | DE2315563A1 (Direct) |
| ES (1) | ES413100A1 (Direct) |
| FR (1) | FR2182909B1 (Direct) |
| GB (1) | GB1441098A (Direct) |
| HU (1) | HU171383B (Direct) |
| IL (1) | IL41902A (Direct) |
| IT (1) | IT1035061B (Direct) |
| NL (1) | NL7304320A (Direct) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1980000412A1 (en) * | 1978-08-24 | 1980-03-20 | N Gilmour | Pasteurellosis vaccines |
| US4293545A (en) | 1980-03-31 | 1981-10-06 | Norden Laboratories, Inc. | Modified Pasteurella multocida bacteria vaccines |
| US4335106A (en) | 1980-03-31 | 1982-06-15 | Norden Laboratories Inc. | Processes for the growth of a modified Pasteurella multocida bacteria and preparation of a vaccine therefrom |
| US4328210A (en) | 1980-03-31 | 1982-05-04 | Norden Laboratories, Inc. | Modified Pasteurella bacteria and vaccines prepared therefrom |
| US4388299A (en) | 1980-03-31 | 1983-06-14 | Norden Laboratories, Inc. | Modified pasteurella bacteria and vaccines prepared therefrom |
| US4559306A (en) * | 1981-04-17 | 1985-12-17 | Norden Laboratories, Inc. | Modified Pasteurella multocida bacteria |
| US4506017A (en) * | 1981-04-17 | 1985-03-19 | Norden Laboratories, Inc. | Modified Pasteurella haemolytica bacteria |
| US4626430A (en) * | 1981-04-17 | 1986-12-02 | Norden Laboratories, Inc. | Processes for growth of modified Pasteurella haemolytica bacteria and preparation of a vaccine therefrom |
| NL8200392A (nl) * | 1982-02-03 | 1983-09-01 | Duphar Int Res | Werkwijze ter bereiding van een immunogeen van pasteurella multocida. |
| JPH0662433B2 (ja) * | 1984-04-23 | 1994-08-17 | 財団法人日本生物科学研究所 | ヘモフイルス・パラガリナ−ラムの粉状ワクチン製造法 |
| GB2202851B (en) * | 1987-03-24 | 1990-12-19 | Nat Res Dev | Proteinaceous material of p. haemolytica and vaccine against pasteurella |
| MX9301736A (es) * | 1992-03-30 | 1994-01-31 | Smithkline Beecham Corp | Vacuna de bacterina-toxoide de pasteurella haemolytica tipo a-1. |
-
1973
- 1973-02-07 GB GB593573*[A patent/GB1441098A/en not_active Expired
- 1973-03-28 JP JP48035564A patent/JPS496118A/ja active Pending
- 1973-03-28 NL NL7304320A patent/NL7304320A/xx unknown
- 1973-03-28 IT IT49108/73A patent/IT1035061B/it active
- 1973-03-28 ES ES413100A patent/ES413100A1/es not_active Expired
- 1973-03-28 DE DE2315563A patent/DE2315563A1/de active Pending
- 1973-03-28 IL IL41902A patent/IL41902A/en unknown
- 1973-03-28 FR FR7311142A patent/FR2182909B1/fr not_active Expired
- 1973-03-29 HU HU73WE00000484A patent/HU171383B/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE2315563A1 (de) | 1973-10-11 |
| HU171383B (hu) | 1977-12-28 |
| ES413100A1 (es) | 1976-06-01 |
| GB1441098A (en) | 1976-06-30 |
| NL7304320A (Direct) | 1973-10-02 |
| JPS496118A (Direct) | 1974-01-19 |
| IT1035061B (it) | 1979-10-20 |
| IL41902A0 (en) | 1973-05-31 |
| FR2182909B1 (Direct) | 1976-04-09 |
| FR2182909A1 (Direct) | 1973-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mourad et al. | Passive immunization of mice against Candida albicans | |
| EP2932979B1 (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
| IL41902A (en) | Immunogenic substance,its production,vaccine preparations containing it and their preparation | |
| Angerman et al. | Comparative efficacy and toxicity of a ribosomal vaccine, acetone-killed cells, lipopolysaccharide, and a live cell vaccine prepared from Salmonella typhhimurium | |
| Egerton | Surface and somatic antigens of Fusiformis nodosus | |
| EP0020356A1 (en) | PASTEURELLOSIS VACCINES. | |
| BR112015013513B1 (pt) | Composição de conjugado de proteína polissacarídica pneumocócica multivalente | |
| BR122016004924A2 (pt) | Polipeptídeo isolado e composições imunogênicas compreendendo os mesmos | |
| CN101402666B (zh) | 具有免疫佐剂作用的皂苷及其制备方法和含该皂苷为佐剂的疫苗制剂及用途 | |
| CA2402935A1 (en) | Adjuvant for vaccines | |
| Abrahams | Further studies on acquired resistance to murine cryptococcosis: enhancing effect of Bordetella pertussis | |
| US3928565A (en) | Pharmaceutical preparation of pseudomonas aeruginosa bacterial component possessing anti-tumor and anti-infection properties | |
| KR101864029B1 (ko) | 다회투여량 혼합 백신 조성물 | |
| JP2015091795A (ja) | 鼻粘膜ワクチン組成物 | |
| CN101337070B (zh) | 冻干甲型肝炎减毒活疫苗及其制备方法 | |
| US4057626A (en) | Process for detoxifying influenza B virus | |
| Garçon et al. | Development and evaluation of AS04, a novel and improved adjuvant system containing 3-o-desacyl-4′-monophosphoryl lipid a and aluminum salt | |
| Collins et al. | Heat-Labile Antigens of Salmonella enteritidis II. Mouse-protection Studies | |
| US3987164A (en) | Method for prevention of pseudomonas aeruginosa infections | |
| GB1256457A (en) | Diethylaminoethyldextran (deae-d) as adjuvant for vaccines for active immunisation | |
| CN106075420A (zh) | 多价肺炎球菌‑b型流感嗜血杆菌联合疫苗 | |
| WO2004108156A1 (fr) | Vaccin combine a injection intradermique contenant hevac et bcg et son procede de preparation | |
| EP0030166A1 (en) | Vaccine composition for dental caries | |
| RU2227160C1 (ru) | Штамм бактерий leptospira interrogans "митронов" серогруппы canicola для приготовления вакцины | |
| EP3407899A1 (de) | Immunprophylaxe bei rezidivierenden bakteriellen infektionen |